Published in PLoS One on March 06, 2014
Actions of hydrogen sulfide on sodium transport processes across native distal lung epithelia (Xenopus laevis). PLoS One (2014) 0.84
Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases. Br J Pharmacol (2014) 0.83
SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells. Antioxid Redox Signal (2015) 0.82
Functional Differences Between Placental Micro- and Macrovascular Endothelial Colony-Forming Cells. Stem Cells Transl Med (2016) 0.80
Working with nitric oxide and hydrogen sulfide in biological systems. Am J Physiol Lung Cell Mol Physiol (2014) 0.79
Hydrogen sulfide decreases β-adrenergic agonist-stimulated lung liquid clearance by inhibiting ENaC-mediated transepithelial sodium absorption. Am J Physiol Regul Integr Comp Physiol (2015) 0.77
Stem Cells and Their Mediators - Next Generation Therapy for Bronchopulmonary Dysplasia. Front Med (Lausanne) (2015) 0.77
Calcitonin gene-related peptide protects type II alveolar epithelial cells from hyperoxia-induced DNA damage and cell death. Exp Ther Med (2017) 0.75
Aberrant Pulmonary Vascular Growth and Remodeling in Bronchopulmonary Dysplasia. Front Med (Lausanne) (2016) 0.75
International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors. Pharmacol Rev (2017) 0.75
The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment. Front Med (Lausanne) (2017) 0.75
Sirtuins in mammals: insights into their biological function. Biochem J (2007) 7.60
Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov (2007) 6.28
The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res (2007) 3.15
Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet (2008) 2.90
Bronchopulmonary dysplasia. Lancet (2006) 2.89
Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation (2008) 2.74
Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem (1981) 2.60
Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med (2009) 2.60
SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 2.49
Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension. Sci Transl Med (2010) 2.04
Inhaled hydrogen sulfide protects against ventilator-induced lung injury. Anesthesiology (2010) 2.02
Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax (2012) 1.95
Protective and Detrimental Effects of Sodium Sulfide and Hydrogen Sulfide in Murine Ventilator-induced Lung Injury. Anesthesiology (2011) 1.74
Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids. Circ Res (2009) 1.64
Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol (2004) 1.56
Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med (2005) 1.42
Outcomes of preterm infants <29 weeks gestation over 10-year period in Canada: a cause for concern? J Perinatol (2011) 1.40
Effect of preterm birth on later FEV1: a systematic review and meta-analysis. Thorax (2013) 1.36
Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med (2005) 1.35
Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia. Am J Physiol Lung Cell Mol Physiol (2006) 1.29
Nrf2 increases survival and attenuates alveolar growth inhibition in neonatal mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol (2009) 1.15
Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries. Am J Pathol (2007) 1.13
Oxidative damage to mitochondrial DNA and glutathione oxidation in apoptosis: studies in vivo and in vitro. FASEB J (1999) 1.13
Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond. Curr Opin Pediatr (2013) 1.08
Pulmonary hypertension in bronchopulmonary dysplasia. Semin Perinatol (2013) 1.08
Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal mice. Antioxid Redox Signal (2012) 1.02
Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates CD151-induced endothelial cell proliferation and cell migration. Int J Biochem Cell Biol (2006) 0.98
Effect of hydrogen sulphide on beta-amyloid-induced damage in PC12 cells. Clin Exp Pharmacol Physiol (2007) 0.96
The message in the air: hydrogen sulfide metabolism in chronic respiratory diseases. Respir Physiol Neurobiol (2012) 0.94
Activation of Akt protects alveoli from neonatal oxygen-induced lung injury. Am J Respir Cell Mol Biol (2010) 0.94
Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDL. Biochem J (2009) 0.90
Endothelin-1 inhibits apoptosis of pulmonary arterial smooth muscle in the neonatal rat. Pediatr Res (2006) 0.86
Hydrogen sulfide attenuates particulate matter-induced human lung endothelial barrier disruption via combined reactive oxygen species scavenging and Akt activation. Am J Respir Cell Mol Biol (2012) 0.86
The axonal guidance cue semaphorin 3C contributes to alveolar growth and repair. PLoS One (2013) 0.86
Inhaled nitric oxide for respiratory failure in preterm infants. Neonatology (2012) 0.78
The axonal guidance cue semaphorin 3C contributes to alveolar growth and repair. PLoS One (2013) 0.86